AP1 | Early Access pre-MA

Q: AP1 | Early Access pre-MA

Early Access pre-MA AP1 (Early Access pre- MA ) is an authorisation granted by HAS in France allowing patients to access a promising medicine before marketing approval. It targets innovative treatments addressing unmet medical needs, supported by robust clinical data. AP1 includes a monitoring protocol and real-world data collection.

Early Access pre-MA

AP1 (Early Access pre-MA) is an authorisation granted by HAS in France allowing patients to access a promising medicine before marketing approval.

It targets innovative treatments addressing unmet medical needs, supported by robust clinical data. AP1 includes a monitoring protocol and real-world data collection.